Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content

Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle... Abstract The purpose of this investigation was to validate that in vivo measurement of skeletal muscle attenuation (MA) with computed tomography (CT) is associated with muscle lipid content. Single-slice CT scans performed on phantoms of varying lipid concentrations revealed good concordance between attenuation and lipid concentration ( r 2 = 0.995); increasing the phantom's lipid concentration by 1 g/100 ml decreased its attenuation by ∼1 Hounsfield unit (HU). The test-retest coefficient of variation for two CT scans performed in six volunteers was 0.51% for the midthigh and 0.85% for the midcalf, indicating that the methodological variability is low. Lean subjects had significantly higher ( P < 0.01) MA values (49.2 ± 2.8 HU) than did obese nondiabetic (39.3 ± 7.5 HU) and obese Type 2 diabetic (33.9 ± 4.1 HU) subjects, whereas obese Type 2 diabetic subjects had lower MA values that were not different from obese nondiabetic subjects. There was also good concordance between MA in midthigh and midcalf ( r = 0.60, P < 0.01), psoas ( r = 0.65, P < 0.01), and erector spinae ( r = 0.77, P < 0.01) in subsets of volunteers. In 45 men and women who ranged from lean to obese (body mass index = 18.5 to 35.9 kg/m 2 ), including 10 patients with Type 2 diabetes mellitus, reduced MA was associated with increased muscle fiber lipid content determined with histological oil red O staining ( P = −0.43, P < 0.01). In a subset of these volunteers ( n = 19), triglyceride content in percutaneous biopsy specimens from vastus lateralis was also associated with MA ( r = −0.58, P = 0.019). We conclude that the attenuation of skeletal muscle in vivo determined by CT is related to its lipid content and that this noninvasive method may provide additional information regarding the association between muscle composition and muscle function. triglyceride body composition obesity Type 2 diabetes mellitus Footnotes This project was supported by National Institutes of Health Grants K01 AG-00851-02 (to B. H. Goodpaster), R01 DK-49200-04 (D. E. Kelley), 5M01RR-00056 (General Clinical Research Center), and 1P30DK-46204 (Obesity and Nutrition Research Center). At the time of these studies, R. Ross was a visiting Professor from the School of Physical and Health Education, Queen's University (Kingston, ON, Canada). Address for reprint requests and other correspondence: B. H. Goodpaster, E1140 Biomedical Science Tower, Univ. of Pittsburgh, Pittsburgh, PA 15261 (E-mail: bgood+@pitt.edu ). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “ advertisement ” in accordance with 18 U.S.C. §1734 solely to indicate this fact. Copyright © 2000 the American Physiological Society http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Applied Physiology The American Physiological Society

Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content

Download PDF
8 pages

Loading next page...
 
/lp/the-american-physiological-society/skeletal-muscle-attenuation-determined-by-computed-tomography-is-PoLb5108wh

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
The American Physiological Society
Copyright
Copyright © 2011 the American Physiological Society
ISSN
8750-7587
eISSN
1522-1601
Publisher site
See Article on Publisher Site

Abstract

Abstract The purpose of this investigation was to validate that in vivo measurement of skeletal muscle attenuation (MA) with computed tomography (CT) is associated with muscle lipid content. Single-slice CT scans performed on phantoms of varying lipid concentrations revealed good concordance between attenuation and lipid concentration ( r 2 = 0.995); increasing the phantom's lipid concentration by 1 g/100 ml decreased its attenuation by ∼1 Hounsfield unit (HU). The test-retest coefficient of variation for two CT scans performed in six volunteers was 0.51% for the midthigh and 0.85% for the midcalf, indicating that the methodological variability is low. Lean subjects had significantly higher ( P < 0.01) MA values (49.2 ± 2.8 HU) than did obese nondiabetic (39.3 ± 7.5 HU) and obese Type 2 diabetic (33.9 ± 4.1 HU) subjects, whereas obese Type 2 diabetic subjects had lower MA values that were not different from obese nondiabetic subjects. There was also good concordance between MA in midthigh and midcalf ( r = 0.60, P < 0.01), psoas ( r = 0.65, P < 0.01), and erector spinae ( r = 0.77, P < 0.01) in subsets of volunteers. In 45 men and women who ranged from lean to obese (body mass index = 18.5 to 35.9 kg/m 2 ), including 10 patients with Type 2 diabetes mellitus, reduced MA was associated with increased muscle fiber lipid content determined with histological oil red O staining ( P = −0.43, P < 0.01). In a subset of these volunteers ( n = 19), triglyceride content in percutaneous biopsy specimens from vastus lateralis was also associated with MA ( r = −0.58, P = 0.019). We conclude that the attenuation of skeletal muscle in vivo determined by CT is related to its lipid content and that this noninvasive method may provide additional information regarding the association between muscle composition and muscle function. triglyceride body composition obesity Type 2 diabetes mellitus Footnotes This project was supported by National Institutes of Health Grants K01 AG-00851-02 (to B. H. Goodpaster), R01 DK-49200-04 (D. E. Kelley), 5M01RR-00056 (General Clinical Research Center), and 1P30DK-46204 (Obesity and Nutrition Research Center). At the time of these studies, R. Ross was a visiting Professor from the School of Physical and Health Education, Queen's University (Kingston, ON, Canada). Address for reprint requests and other correspondence: B. H. Goodpaster, E1140 Biomedical Science Tower, Univ. of Pittsburgh, Pittsburgh, PA 15261 (E-mail: bgood+@pitt.edu ). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “ advertisement ” in accordance with 18 U.S.C. §1734 solely to indicate this fact. Copyright © 2000 the American Physiological Society

Journal

Journal of Applied Physiology – The American Physiological Society

Published: Jul 1, 2000

There are no references for this article.